Cell-free DNA concentration as a biomarker of response and recurrence in HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Magbanua MJM, Ahmed Z, Sayaman RW, Brown Swigart L, Hirst GL, Yau C, Wolf DM, Li W, Delson AL, Perlmutter J, Pohlmann P, Symmans WF, Yee D, Hylton NM, Esserman LJ, DeMichele AM, Rugo HS, van 't Veer LJ.
Magbanua MJM, et al. Among authors: yau c.
Clin Cancer Res. 2024 Mar 12. doi: 10.1158/1078-0432.CCR-23-2928. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38470545